Medopharm — Sulfadoxine Exporter Profile
Indian Pharmaceutical Exporter · #5 for Sulfadoxine · $600.0K export value · DGFT Verified
Medopharm is the #5 Indian exporter of Sulfadoxine with $600.0K in export value and 12 verified shipments. Medopharm holds a 1.1% market share in Sulfadoxine exports across 4 countries. The company exports 21 pharmaceutical products worth $50.2M across 10 therapeutic categories.
Medopharm — Sulfadoxine Export Profile: Buyers & Destinations
Where Does Medopharm Export Sulfadoxine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $262.7K | 14 | 36.7% |
| NETHERLANDS | $237.4K | 6 | 33.1% |
| TANZANIA | $100.0K | 2 | 14.0% |
| CAMEROON | $84.2K | 2 | 11.8% |
| ZAMBIA | $32.0K | 2 | 4.5% |
Medopharm exports Sulfadoxine to 5 countries. The largest destination is GERMANY accounting for 36.7% of Medopharm's Sulfadoxine shipments, followed by NETHERLANDS (33.1%) and TANZANIA (14.0%). These destinations reflect Medopharm's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sulfadoxine from Medopharm?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S. IMRES | NETHERLANDS | $108.8K | 3 |
| M/S. THE DIRECTOR GENERAL. | TANZANIA | $100.0K | 2 |
| AMERICAN EMBASSY | CAMEROON | $84.2K | 2 |
| PHILCO PHARMA E K. | GERMANY | $81.2K | 3 |
| PHILCO PHARMA E K | GERMANY | $75.0K | 5 |
| M/S. PHILCO PHARMA E.K | GERMANY | $60.7K | 4 |
| IMRES | NETHERLANDS | $50.0K | 1 |
| IMRES B.V | NETHERLANDS | $50.0K | 1 |
| M S PHILCO PHARMA E K | GERMANY | $45.9K | 2 |
| KARIBU PHARMACEUTICALS LTD | ZAMBIA | $32.0K | 2 |
Medopharm supplies Sulfadoxine to 11 buyers globally. The largest buyer is M/S. IMRES (NETHERLANDS), followed by M/S. THE DIRECTOR GENERAL. (TANZANIA) and AMERICAN EMBASSY (CAMEROON). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sulfadoxine Export Value and How Much Does Medopharm Contribute?
India exported $11.4M worth of Sulfadoxine through 364 shipments from 41 suppliers to 38 countries, serving 74 buyers globally. Medopharm contributes $600.0K to this total, accounting for 1.1% of India's Sulfadoxine exports. Medopharm ships Sulfadoxine to 5 countries through 11 buyers.
What Is the Average Shipment Value for Medopharm's Sulfadoxine Exports?
Medopharm's average Sulfadoxine shipment value is $50.0K per consignment, based on 12 shipments totaling $600.0K. The largest destination is GERMANY (36.7% of Medopharm's Sulfadoxine exports).
How Does Medopharm Compare to Other Indian Sulfadoxine Exporters?
Medopharm ranks #5 among 41 Indian Sulfadoxine exporters with a 1.1% market share. The top 3 exporters are S KANT HEALTHCARE LIMITED ($5.2M), MACLEODS PHARMACEUTICALS LTD ($1.7M), GRACURE PHARMACEUTICALS LIMITED ($1.6M). Medopharm processed 12 shipments to 4 destination countries.
What Sulfadoxine Formulations Does Medopharm Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SULFADOXINE AND PYRIMETHAMINE TABLETS US | $208.8K | 5 |
| SULFADOXINE AND PYRIMETHAMINE TABLETS USP 500 25MG | $84.2K | 2 |
| PHILCO MAX (SULFADOXINE & PYRIMETHAMINE | $60.7K | 4 |
| SULFADOXINE AND PYRIMETHAMINE TABLETS USP (500+25MG) | $50.0K | 1 |
| SULFADOXINE AND PYRIMETHAMINE TABLETS USP (500+25MG) (1000 X 1000)- JAR | $50.0K | 1 |
| PHILCO MAX SULFADOXINE PYRIMETHAMINETABLETS USP 525MG 3000 X 40 X 3 NOS | $45.9K | 2 |
| PHILCO MAX(SULFADOXINE+PYRIMETHAMINE TABLETS USP 525MG (4000 X 40 X 3)- NOS | $29.1K | 1 |
| PHILCO MAX(SULFADOXINE+PYRIMETHAMINE TABLETS USP 525MG) (4000 X 40 X 3) - NOS | $28.9K | 1 |
| SULFADOXINE AND PYRIMETHAMINE TABLETS USP 500+25MG 500 X 1000 - JAR | $28.6K | 1 |
| PHILCO MAX (SULFADOXINE+PYRIMETHAMINE TABLETS USP 525MG) (3700 X 40 X 3) - NOS | $28.3K | 1 |
Medopharm exports 17 distinct Sulfadoxine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SULFADOXINE AND PYRIMETHAMINE TABLETS US with 5 shipments worth $208.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Sulfadoxine to Key Markets
What Medopharm must comply with to export Sulfadoxine to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Medopharm Compare to Nearest Sulfadoxine Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | GRACURE PHARMACEUTICALS LIMITED | $1.6M | 39 | 1 | $40.2K |
| 4 | S K AGE EXPORTS | $750.0K | 15 | 3 | $50.0K |
| 5 | MEDOPHARM ★ | $600.0K | 12 | 4 | $50.0K |
| 7 | SHALINA LABORATORIES PRIVATE LIMITED | $574.8K | 38 | 9 | $15.1K |
| 6 | LABORATE PHARMACEUTICALS INDIA LTD | $400.0K | 8 | 1 | $50.0K |
Medopharm ranks #5 among 41 Indian Sulfadoxine exporters. Average shipment value of $50.0K compared to the market average of $279.0K. The closest competitors by value are GRACURE PHARMACEUTICALS LIMITED and S K AGE EXPORTS.
Which Indian Ports Ship Sulfadoxine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 69 | 19.0% |
| JNPT/ NHAVA SHEVA SEA | 51 | 14.0% |
| JNPT | 37 | 10.2% |
| NHAVA SHEVA | 32 | 8.8% |
| PATLI ICD (INPTL6) | 20 | 5.5% |
| SAHAR AIR | 18 | 4.9% |
| CHENNAI SEA (INMAA1) | 13 | 3.6% |
| KAMARAJAR PORT (INENR1) | 11 | 3.0% |
What Other Antimalarial & Antiparasitic Products Does Medopharm Export?
Medopharm also exports these antimalarial & antiparasitic products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medopharm's Sulfadoxine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medopharm. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions have particularly impacted trade corridors through the Persian Gulf and the Strait of Hormuz, vital for India's drug shipments. (pharmaceuticalcommerce.com)
Conversely, US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of 100% tariffs on branded or patented pharmaceutical products by the US in October 2025 poses a significant challenge. While generic drugs may remain largely unaffected, companies like Medopharm must navigate these policy shifts carefully. (itisbl.com)
The recent India–European Union Free Trade Agreement, concluded in January 2026, offers a favorable development. The agreement eliminates tariffs on most European pharmaceutical exports to India and vice versa, potentially enhancing market access for Indian companies in the EU. (en.wikipedia.org)
Medopharm — Regulatory Compliance & Quality Standards
India's pharmaceutical industry has made significant strides in regulatory compliance, with the country surpassing the US in the number of FDA-registered generic manufacturing sites as of 2024. This achievement reflects improved adherence to international quality standards, a critical factor for exporters like Medopharm. (business-standard.com)
However, the industry faces challenges related to quality compliance, as evidenced by incidents involving contaminated products. Maintaining rigorous quality control measures is essential for sustaining global trust and market access. (economictimes.indiatimes.com)
About Medopharm
Medopharm exports 21 products worth $50.2M. Beyond Sulfadoxine, top products include Amoxicillin, Metronidazole, Paracetamol, Albendazole, Ciprofloxacin. View the complete Medopharm profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sulfadoxine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sulfadoxine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medopharm matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 26 individual customs records matching Medopharm exporting Sulfadoxine, covering 17 formulations to 5 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 38+ countries, 74+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sulfadoxine Export Data from Medopharm
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medopharm's Sulfadoxine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medopharm
Full Company Profile →
21 products · $50.2M total trade · 10 categories
Sulfadoxine Stats
Company Overview
Top Products by Medopharm
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medopharm.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sulfadoxine. For current shipment-level data, contact TransData Nexus.